Azmi Nabulsi

2021

In 2021, Azmi Nabulsi earned a total compensation of $4.3M as Chief Operating Officer at Phathom Pharmaceuticals, a 83% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$285,846
Option Awards$3,529,515
Salary$491,250
Other$14,625
Total$4,321,236

Nabulsi received $3.5M in option awards, accounting for 82% of the total pay in 2021.

Nabulsi also received $285.8K in non-equity incentive plan, $491.3K in salary and $14.6K in other compensation.

Rankings

In 2021, Azmi Nabulsi's compensation ranked 3,071st out of 12,415 executives tracked by ExecPay. In other words, Nabulsi earned more than 75.3% of executives.

ClassificationRankingPercentile
All
3,071
out of 12,415
75th
Division
Manufacturing
1,228
out of 5,505
78th
Major group
Chemicals And Allied Products
491
out of 2,375
79th
Industry group
Drugs
434
out of 2,096
79th
Industry
Pharmaceutical Preparations
296
out of 1,546
81st
Source: SEC filing on April 13, 2023.

Nabulsi's colleagues

We found one more compensation record of an executive who worked with Azmi Nabulsi at Phathom Pharmaceuticals in 2021.

2021

Terrie Curran

Phathom Pharmaceuticals

Chief Executive Officer

News

In-depth

You may also like